Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact
Login Book a demo
Prenosis logo — Transforming clinical diagnosis with predictive intelligence...

Prenosis

Transforming clinical diagnosis with predictive intelligence.

Founded 2014 United States Chicago, United States 36 employees Grant Total: $11.45M AI, Biopharma +3

General Information

Company Name Prenosis
Founded Year 2014
Location United States Chicago, United States
Founders / Decision Makers
Team member
Employees 36
Industries AI, Biopharma, Health Care +2
Funding Stage Grant
Social

BounceWatch is an independent company data service, not affiliated with Prenosis. To contact Prenosis, visit prenosis.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Prenosis compare?

A PDF of Prenosis and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Prenosis soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About Prenosis

Prenosis is a biopharma and health care startup founded in 2014 with the slogan "Transforming clinical diagnosis with predictive intelligence." The company's core focus is transforming clinical diagnosis through the use of artificial intelligence that utilizes a holistic approach to molecular and clinical data.

Based in the United States, Prenosis recently secured a significant $4.80M grant investment on 12 July 2023. The investment came from the National Institute of General Medical Science, highlighting the company's recognition and support from reputable industry players.

Overall, Prenosis appears to be an innovative player in the biopharma and healthcare sectors, leveraging cutting-edge technology and data analysis to improve the accuracy and efficiency of clinical diagnosis. Their recent investment is a testament to their potential and the confidence of notable investors in their mission.

Business keywords: clinical diagnosis, predictive intelligence, molecular data, clinical data, diagnostic technology, data-driven healthcare, precision medicine

Funding Rounds & Investors (6)

View All
Funding Stage Amount Investors Lead Investors Date
Grant $4.80M 1
National Institute of General Medical Science
12 Jul 2023
Venture Round Undisclosed 1
PACE Healthcare Capital
PACE Healthcare Capital
09 Mar 2022
Grant $4.30M 1
Defense Threat Reduction Agency (DTRA)
17 Nov 2021
Grant $704.53K 1
National Science Foundation
National Science Foundation
18 Sep 2018
Grant $150.00K 1
National Science Foundation
National Science Foundation
10 Jul 2017
Venture Round $1.50M -
07 Sep 2016

Latest News

View All
FDA authorizes Prenosis software as first AI tool that can diagnose sepsis — Cnbc
FDA authorizes Prenosis software as first AI tool that can diagnose sepsis
Cnbc Apr 03, 2024

Prenosis Alternatives & Competitors

View All Alternatives
Prenosis vs
Voythos
Voythos United States

Transforming aortic disease with predictive intelligence.

Pre-Seed
2 employees
AI, Health Care
Compare Prenosis vs Voythos
Prenosis vs
Legit.Health
Legit.Health Spain

Artificial Intelligence software for early detection, evaluation and monitoring of skin diseases.

Grant
34 employees
AI, Computer Vision
Compare Prenosis vs Legit.Health
Prenosis vs
Cohesic Inc
Cohesic Inc Canada

BETTER CARE THROUGH BETTER DATA

Seed
21 employees
AI, Health Care
View all alternatives

FAQ About Prenosis

Transforming clinical diagnosis with predictive intelligence.
Prenosis was founded in 2014.
Prenosis is headquartered in Chicago, United States.
Prenosis operates in AI, Biopharma, Health Care, Pharmaceutical and Machine Learning. Its work centres on clinical diagnosis, predictive intelligence, molecular data and clinical data.
Prenosis has approximately 36 employees.
Prenosis has completed 6 funding rounds, raising a total of $11.45M. The latest funding stage is Grant.
Top alternatives and competitors to Prenosis include Voythos, Legit.Health, Cohesic Inc, 赛纳生物科技(北京)有限公司, Orbuculum Genolytics Pvt Ltd. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Prenosis and Voythos are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Prenosis, https://bouncewatch.com/company/prenosis, updated 25 November 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes